There were 1,860 press releases posted in the last 24 hours and 427,030 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Vaccinex Details Scientific Rationale for Expanding Pepinemab Clinical Programs to Include Alzheimer’s Disease

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image